Utility of a Screening Test (MoCa) to Predict Amyloid Physiopathology in Mild Cognitive Impairment
J. Appl. Cogn. Neurosci. (Barranquilla); 1 (1), 2020
Introduction: The MoCa (Montreal Cognitive Assessment) Screening test has become relevant in recent years in the screening of patients with Mild Cognitive Impairment (MCI). It is important to seek and study simple and reliable tools in clinical practices that correlate with biological markers that have b...